Cosentyx subcutaneous — Medica
Non-Radiographic Spondyloarthritis (nr-axSpA)
Preferred products
- Cimzia
- Taltz
- Rinvoq
Initial criteria
- Patient meets the standard Inflammatory Conditions – Cosentyx Subcutaneous Prior Authorization Policy criteria
- Patient has tried TWO of Cimzia, Taltz, and Rinvoq (Enbrel, adalimumab products, infliximab products, or Simponi also count)
Approval duration
6 months